Latest Insider Transactions at Becton Dickinson & CO (BDX)
This section provides a real-time view of insider transactions for Becton Dickinson & CO (BDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BECTON DICKINSON & CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BECTON DICKINSON & CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2022
|
Richard Byrd EVP & President Interventional |
BUY
Grant, award, or other acquisition
|
Direct |
2,501
+18.35%
|
-
|
|
Nov 26
2022
|
Michael David Garrison EVP & President Medical |
SELL
Payment of exercise price or tax liability
|
Direct |
617
-8.49%
|
-
|
|
Nov 26
2022
|
Michael David Garrison EVP & President Medical |
BUY
Grant, award, or other acquisition
|
Direct |
2,790
+17.5%
|
-
|
|
Nov 16
2022
|
Roland Goette EVP and President EMEA |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,996
-20.11%
|
$665,112
$222.08 P/Share
|
|
Nov 16
2022
|
Roland Goette EVP and President EMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
4,617
+23.66%
|
$341,658
$74.94 P/Share
|
|
Sep 07
2022
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-5.25%
|
-
|
|
Sep 01
2022
|
Christopher Del Orefice EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,674
+21.71%
|
-
|
|
Aug 15
2022
|
Thomas E Polen Jr Chairman, CEO and President |
SELL
Open market or private sale
|
Direct |
9,500
-24.75%
|
$2,517,500
$265.13 P/Share
|
|
Aug 15
2022
|
Thomas E Polen Jr Chairman, CEO and President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,500
-12.53%
|
$1,457,500
$265.13 P/Share
|
|
Aug 15
2022
|
Thomas E Polen Jr Chairman, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+25.48%
|
$2,505,000
$167.91 P/Share
|
|
Aug 15
2022
|
David Hickey EVP & President, Life Sciences |
SELL
Open market or private sale
|
Direct |
475
-12.48%
|
$125,875
$265.0 P/Share
|
|
Aug 09
2022
|
Samrat S. Khichi EVP and General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,335
-26.79%
|
$2,687,100
$260.44 P/Share
|
|
Aug 09
2022
|
Samrat S. Khichi EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
26,815
+40.92%
|
$2,681,500
$100.87 P/Share
|
|
Aug 09
2022
|
Samrat S. Khichi EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
9,185
-60.78%
|
$2,388,100
$260.44 P/Share
|
|
Aug 09
2022
|
Thomas E Polen Jr Chairman, CEO and President |
SELL
Open market or private sale
|
Direct |
1,652
-5.41%
|
$429,520
$260.0 P/Share
|
|
Aug 09
2022
|
Thomas E Polen Jr Chairman, CEO and President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,173
-6.64%
|
$564,980
$260.0 P/Share
|
|
Aug 09
2022
|
Thomas E Polen Jr Chairman, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+10.47%
|
$562,275
$147.68 P/Share
|
|
Aug 08
2022
|
Samrat S. Khichi EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
7,295
-55.17%
|
$1,896,700
$260.44 P/Share
|
|
Jul 08
2022
|
Rishi Grover EVP and Chief ISC Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,340
+49.74%
|
-
|
|
Jul 01
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
BUY
Grant, award, or other acquisition
|
Direct |
420
+22.13%
|
-
|
|
Jun 17
2022
|
James C Lim Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
3,280
+12.05%
|
-
|
|
Jun 07
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Open market or private sale
|
Direct |
443
-29.51%
|
$115,180
$260.0 P/Share
|
|
Jun 07
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Sale (or disposition) back to the issuer
|
Direct |
583
-28.16%
|
$151,580
$260.0 P/Share
|
|
Jun 07
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
BUY
Exercise of conversion of derivative security
|
Direct |
1,026
+33.14%
|
$150,822
$147.68 P/Share
|
|
May 06
2022
|
David Hickey EVP & President, Life Sciences |
SELL
Open market or private sale
|
Direct |
475
-11.1%
|
$121,600
$256.0 P/Share
|
|
Apr 06
2022
|
Shana Carol Neal EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,525
+49.76%
|
-
|
|
Mar 02
2022
|
Antoine C Ezell EVP, President NA & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
610
-7.69%
|
-
|
|
Mar 01
2022
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Payment of exercise price or tax liability
|
Direct |
35
-3.24%
|
-
|
|
Mar 01
2022
|
Antoine C Ezell EVP, President NA & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-3.36%
|
-
|
|
Feb 28
2022
|
William M Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
714
+50.0%
|
-
|
|
Feb 25
2022
|
Betty D Larson EVP HR & CHRO |
SELL
Open market or private sale
|
Direct |
14,374
-20.51%
|
$3,895,354
$271.9 P/Share
|
|
Feb 25
2022
|
Betty D Larson EVP HR & CHRO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
32,284
-32.4%
|
$8,748,964
$271.9 P/Share
|
|
Feb 25
2022
|
Betty D Larson EVP HR & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
46,658
+31.01%
|
$9,004,994
$193.09 P/Share
|
|
Feb 11
2022
|
Simon D Campion EVP and Segment President |
SELL
Bona fide gift
|
Direct |
50
-0.48%
|
-
|
|
Feb 08
2022
|
Claire Fraser Director |
SELL
Open market or private sale
|
Direct |
841
-3.76%
|
$227,911
$271.7 P/Share
|
|
Feb 08
2022
|
Samrat S. Khichi EVP and General Counsel |
SELL
Bona fide gift
|
Direct |
375
-5.95%
|
-
|
|
Feb 03
2022
|
Alexandre Conroy EVP of Integrated Supply Chain |
SELL
Open market or private sale
|
Direct |
6,410
-23.17%
|
$1,730,700
$270.16 P/Share
|
|
Feb 03
2022
|
Alexandre Conroy EVP of Integrated Supply Chain |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,377
-18.73%
|
$1,721,790
$270.16 P/Share
|
|
Feb 03
2022
|
Alexandre Conroy EVP of Integrated Supply Chain |
BUY
Exercise of conversion of derivative security
|
Direct |
12,787
+27.3%
|
$1,713,458
$134.73 P/Share
|
|
Jan 27
2022
|
Simon D Campion EVP and Segment President |
SELL
Payment of exercise price or tax liability
|
Direct |
190
-1.8%
|
-
|
|
Jan 25
2022
|
Claire Fraser Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+3.53%
|
-
|
|
Jan 25
2022
|
Catherine M Burzik Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+6.16%
|
-
|
|
Jan 25
2022
|
Marshall O Larsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+3.33%
|
-
|
|
Jan 25
2022
|
David F Melcher Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+11.71%
|
-
|
|
Jan 25
2022
|
Timothy M Ring Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+1.04%
|
-
|
|
Jan 25
2022
|
Carrie L Byington Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+44.04%
|
-
|
|
Jan 25
2022
|
R Andrew Eckert Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+11.65%
|
-
|
|
Jan 25
2022
|
Jeffrey William Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+17.84%
|
-
|
|
Jan 25
2022
|
Claire Pomeroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+7.59%
|
-
|
|
Jan 25
2022
|
Bertram L Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
820
+2.51%
|
-
|